SGO on the GO

Oct 28 2024 69 ep. 20 mins 17

SGO on the GO Podcast artwork

SGO on the GO is the Society of Gynecologic Oncology's best education for the busy clinician. Join us for discussions regarding clinical practice, advances in research, and other compelling topics relevant to gynecologic oncology.

Health & Fitness

Copy RSS

Subscribe on Podcast Addict

SGO Oncofertility Part 2: Risks of Premature Ovarian Failure

Oct 28 2024 14 mins

Maximizing reproductive fertility options is just as important as beating cancer, primarily bridging the gap for patient education and fertility resources. Join Dr. Jennifer MacDonald as she interviews Drs. Scott Richard and Rachel Danis, addressing premature ovarian failure, ovarian preservation, and how chemo agents, radiation, and surgery can affect the patient’s natural ferti

SGO Oncofertility Part 1: Giving Patients Ownership of their Future Fertility Options

Oct 28 2024 26 mins

Listen to Dr. Jennifer MacDonald interview Drs. Scott Richard and Rachel Danis, discussing the importance of fertility preservation for cancer patients, partnering with a reproductive endocrinology and infertility clinic (REI) to expand fertility options for future family building, and patients utilizing grant/nonprofit funding resources to financially assist with fertility treatme

Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (CDK 4/6 inhibitors)

Oct 08 2024 16 mins

This is the last of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the challenges with patient monitoring while on CDK 4/6 inhibitors. When to dose adjust and hold or even discontinue CDK 4/6 inhibitors. Once again, the podcast ends with take home points for patient monitoring, medication management, and sid

Part 2: Keeping up with the Chemos Series: Administration of CDK 4/6 inhibitors

Oct 08 2024 16 mins

This is the second of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of CDK 4/6 inhibitors. Focusing on dosing, supportive care, and patient education. The session ends with general take home points on administration and toxicity prevent

Part 1: Keeping up with the Chemos Series: Preparing to Give CDK 4/6 inhibitors

Oct 08 2024 10 mins

This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The

Encouraging Self-Advocacy in the Cervical Cancer Journey

Oct 04 2024 26 mins

Let’s do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee.Moderators:Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Hea

Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trastuzumab Deruxtecan ENHERTU®)

Jun 18 2024 11 mins

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient

Part 2: Keeping up with the Chemos Series: Administration of Trastuzumab Deruxtecan ENHERTU®

Jun 18 2024 14 mins

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®. Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session en

Part 1: Keeping up with the Chemos Series: Preparing to Give Trastuzumab Deruxtecan ENHERTU®

Jun 18 2024 21 mins

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss do

ERAS Guidelines: Same Day Discharge (SDD)

May 03 2024 13 mins

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activi